Nuts and Bolts of Fecal Microbiota Transplantation.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
01 2019
Historique:
received: 24 05 2018
revised: 14 09 2018
accepted: 19 09 2018
pubmed: 1 10 2018
medline: 11 3 2020
entrez: 1 10 2018
Statut: ppublish

Résumé

Clostridium difficile infection (CDI) has become the leading cause of nosocomial infection in the United States with significant risk of both morbidity and mortality. While antimicrobial therapy forms the basis of treatment, there are several clinical scenarios in which antimicrobial therapy alone is insufficient. Evidence continues to show the safety and efficacy fecal microbiota transplantation (FMT) in recurrent and severe CDI. This review will outline FMT efficacy, safety, and indications and present practical advice for clinicians interested in best practices around delivery of FMT.

Identifiants

pubmed: 30268564
pii: S1542-3565(18)31020-6
doi: 10.1016/j.cgh.2018.09.029
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-352

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Edward Krajicek (E)

Division of Gastroenterology, Indiana University, Indianapolis, Indiana.

Monika Fischer (M)

Division of Gastroenterology, Indiana University, Indianapolis, Indiana.

Jessica R Allegretti (JR)

Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts.

Colleen R Kelly (CR)

Division of Gastroenterology, Alpert Medical School of Brown University, Providence, Rhode Island. Electronic address: colleen_r_kelly@brown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH